Reduction of interstitial fluid pressure after TNF-α treatment of three human melanoma xenografts

British Journal of Cancer

Volumn 74, Issue 4, 1996, Pages 533-536

  Kristensen, C A ^a   Nozue, M ^a   Boucher, Y ^a   Jain, R K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood pressure; Interstitial fluid pressure; Melanoma xenograft; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TRANSPLANTATION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE PRESSURE; XENOGRAFT;

EID: 0029758308     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.397     Document Type: Article

References (20)

1. AMIKURA K, YEO K-T, DVORAK HF, ALEXANDER HR AND FRAKER DL. (1995). Expression of vascular endothelial growth factor correlates with tumor necrosis factor cytotoxicity in vivo. (abstract). Proc. Am. Assoc. Cancer Res., 36, 468.
2. ASHER A, MULÉ JJ, REICHERT CM, SHILONI E AND ROSENBERG SA. (1987). Studies on the anti-tumour efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J. Immunol., 138, 963 - 974.
3. BAUDRY N AND VICAUT E. (1993). Role of nitric oxide in effects of tumor necrosis factor-α on microcirculation in rat. J. Appl. Physiol., 75, 2392 - 2399.
4. BOUCHER Y AND JAIN RK. (1992). Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res., 52, 5110 - 5114.
5. BOUCHER Y, KIRKWOOD JM, OPACIC D, DESANTIS M AND JAIN RK. (1991). Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res., 51, 6691 - 9994.
6. CURTI BD, URBA WJ, ALVORD WG, JANIK JE, SMITH II JW, MADARA K AND LONGO DL. (1993). Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res., 53, 2204 - 2207.
7. FOLLI S, PELEGRIN A, CHALANDON Y, YAO X, BUCHEGGER F, LIENARD D, LEJEUNE F AND MACH J-P. (1993). Tumor necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability. Int. J. Cancer, 53, 829 - 836.
8. FRAKER DL AND ALEXANDER HR. (1993). The use of tumor necrosis factor in isolated limb perfusions for melanoma and sarcoma. Prin. Practice Oncol., 7, 1 - 10.
9. JAIN RK. (1994). Transport phenomena in tumors. Adv. Chem. Eng., 19, 129 - 200.
10. KETTELHUT IC, FIERS W AND GOLDBERG AL. (1987). The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc. Natl Acad. Sci. USA, 84, 4273 - 4277.
11. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl Acad. Sci. USA, 87, 3629 - 3632.
12. KRISTJANSEN PEG, BOUCHER Y AND JAIN RK. (1993). Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. Cancer Res., 53, 4764 - 4766.
13. LIENARD D, EWALENKO P, DELMOTTE J-J, RENARD N AND LEJEUNE FJ. (1992). High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol., 10, 52 - 60.
14. NETTI PA, BAXTER LT, BOUCHER Y, SKALAK R AND JAIN RK. (1995). Time-dependent behaviour of interstitial fluid pressure inside tumors: implications for drug delivery. Cancer Res., 55, 5451 - 5458.
15. ROWLINSON-BUSZA G, MARAVEYAS A AND EPENETOS AA (1995). Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model. Br. J. Cancer, 71, 660 - 665.
16. TRACEY KJ, FONG Y, HESSE DG, MANOGUE KR, LEE AT, KUO GC, LOWRY SF AND CERAMI A. (1987). Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, 330, 662 - 664.
17. TUFTO I AND ROFSTAD EK. (1995). Interstitial fluid pressure in human melanoma xenografts. Relationship to fractional tumor water content, tumor size, and tumor volume-doubling time. Acta Oncol., 34, 361-365.
18. VAGLINI M, BELLI F, AMMATUNA M, INGLESE MG, MANZI R, PRADA A, PERSIANI L, SANTINAMI M, SANTORO N AND CASCINELLI N. (1994). Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. Cancer, 73, 483-492.
19. ZLOTECKI RA, BOUCHER Y, LEE I, BAXTER LT AND JAIN RK. (1993). Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure. Cancer Res., 53, 2466 - 2468.
20. ZLOTECKI RA, BAXTER LT, BOUCHER Y AND JAIN RK. (1995). Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvasc. Res., 50, 429- 443.